Thomas Woiwode - Insider Trading & Ownership

Location
One Sansome Street, Suite 1650, San Francisco, CA
Summary
The estimated net worth of Thomas Woiwode is at least $5M dollars as of May 26, 2023. Thomas Woiwode is the Director of Tempest Therapeutics, Inc. and owns shares of Tempest Therapeutics, Inc. (TPST) stock worth about $5M. Thomas Woiwode is the Director of Gritstone bio, Inc. and owns shares of Gritstone bio, Inc. stock worth about $244.
Signature
/s/ Edgar Cale, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Thomas Woiwode

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TPST Tempest Therapeutics, Inc. Director $5M Jun 17, 2022
GRTS Gritstone bio, Inc. Director $244 Aug 25, 2021
ADVM Adverum Biotechnologies, Inc. Director May 12, 2021
ALGS Aligos Therapeutics, Inc. Director Jun 23, 2022
PASG Passage BIO, Inc. Director, 10%+ Owner May 25, 2023

Insider Transactions Reported by Thomas Woiwode:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.